External broker reports(aggregated public sources), Axis Direct

Axis Direct

Axis Direct is the flagship brand under Axis Securities Limited, a subsidiary of Axis Bank in India. 

Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only.  Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

External broker reports(aggregated public sources)

Axis Direct is the flagship brand under Axis Securities Limited, a subsidiary of Axis Bank in India. 

Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only. Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

Equity Bottom-Up

HealthCare Global Enterprises / Equity Bottom-Up

<ul><li>HCG is one of India's leading cancer care providers, operating 21 comprehensive centres dedicated to advanced treatment.</li><li>Its multidisciplinary team uses evidence to create treatment plans that are likely to be successful</li><li>HCG delivered a strong revenue beat with 16.7% YoY growth, supported by 257 new beds, a 15.7% rise in occupied bed days, and improved occupancy of 67% (like-for-like AOR at 76%), while ARPOB remained stable at Rs 44,751.</li></ul><p><em>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.</em></p>

HCG is one of India's leading cancer care providers, operating 21 comprehensive centres dedicated to advanced treatment.Its multidisciplinary team uses evidence to create treatment plans that are likely to be successfulHCG delivered a strong revenue beat with 16.7% YoY growth, supported by 257 new beds, a 15.7% rise in occupied bed days, and improved occupancy of 67% (like-for-like AOR at 76%), while ARPOB remained stable at Rs 44,751.Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Pick of the Week: Healthcare Global Enterprise Ltd - 04th October, 2025